MVP — Medical Developments International Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$48.76m
- AU$35.49m
- AU$32.34m
- 44
- 67
- 39
- 51
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 20.9 | 0.358 | 0.044 | 0.14 | 0.218 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | 21.3 | 0.172 | -8.89 | -10.8 | -17.1 |
Capital Expenditures | -9.87 | -8.9 | -6.56 | -5.21 | -7.67 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.33 | 0.429 | 0.082 | 0.055 | 0.566 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -9.54 | -8.47 | -6.48 | -5.16 | -7.1 |
Financing Cash Flow Items | -1.04 | -0.013 | -0.727 | -0.003 | -1.68 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 13 | -1.97 | 36.1 | 0.142 | 28.1 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 24.8 | -10.1 | 20.7 | -15.9 | 4.26 |